Tejal Desai named chair of the Department of Bioengineering and Therapeutic Sciences
Tejal Desai, PhD, has been named the new chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine. Her appointment is effective August 1, 2014.
A UCSF faculty member since 2005, Desai has been serving as BTS vice chair. “Tejal’s willingness to serve as department chair is characteristic of her collegial approach to science and education,” said Dean B. Joseph Guglielmo, PharmD. “She is an award-winning bioengineer and an accomplished teacher and administrator who has the deep respect of the faculty. I’m very pleased Tejal has accepted the chair position.”
Desai replaces Kathy Giacomini, PhD, who stepped down to lead the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation, which is funded by the U.S. Food and Drug Administration. BTS was previously co-chaired by Giacomini and Sarah Nelson, PhD.
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American west. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.